Cardiovascular disease management in Australian adults with type 2 diabetes: insights from the CAPTURE study.
Timothy M E DavisPeter G ColmanCharlotte HespeSarah E HeywoodMichael d'EmdenPublished in: Internal medicine journal (2022)
Use of BGLMs with CVD benefits appears low in Australia, irrespective of CVD status. This likely reflects the delay in translation of clinical evidence into contemporary care and prescribing restrictions.